169P Immunomodulatory effects of RBS2418, an oral ENPP1 inhibitor in combination with pembrolizumab in checkpoint-refractory metastatic adrenal cancer
| Autor: | Csiki, I., Glenn, J., Schanzer, J., Tuan, B., Huang, N., Dong, A., John, E., O'Toole, L., Seppa, J., Hawley, R., Exon, C., Klumpp, K. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2022 16 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|